Key facts
- This page summarizes Michael McGarrity's Form 3 filing for MDxHealth SA (MDXH).
- 0 reported transactions and 12 derivative rows are listed below.
- Accepted by SEC: 13 Apr 2026, 16:05.
Michael McGarrity - 18 Mar 2026 Form 3 Insider Report for MDxHealth SA (MDXH)
- Reporting relationship
- Chief Executive Officer, Director
- Issuer ticker
- MDXH
- Reported as of
- 18 Mar 2026
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 13 Apr 2026, 16:05:08 UTC
- Next SEC filing
- 03 Jun 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Mark Busch, as attorney-in-fact for Michael McGarrity
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Michael McGarrity filed Form 3 for MDxHealth SA (MDXH) on 13 Apr 2026.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reporting Owners (1)
CIK 0001416842
Primary reporting owner
McGarrity Michael
- Relationship
- Chief Executive Officer, Director
- Address
- CAP BUSINESS CENTER, ZONE INDUSTRIELLE DES HAUTS-SARTS, HERSTAL, BELGIUM
- Signature
- /s/ Mark Busch, as attorney-in-fact for Michael McGarrity
- Signature date
- 13 Apr 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
MDXH
holding
Ordinary Shares
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 95,000
- Date
- 18 Mar 2026
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
MDXH
holding
Derivative
Share Option
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 18 Mar 2026
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 150,000
- Exercise price
- Footnotes
- F1
MDXH
holding
Derivative
Share Option
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 18 Mar 2026
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 22,500
- Exercise price
- Footnotes
- F2
MDXH
holding
Derivative
Share Option
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 18 Mar 2026
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 16,875
- Exercise price
- Footnotes
- F3
MDXH
holding
Derivative
Share Option
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 18 Mar 2026
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 50,000
- Exercise price
- Footnotes
- F4
MDXH
holding
Derivative
Share Option
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 18 Mar 2026
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 50,000
- Exercise price
- Footnotes
- F5
MDXH
holding
Derivative
Share Option
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 18 Mar 2026
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 50,000
- Exercise price
- Footnotes
- F6
MDXH
holding
Derivative
Share Option
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 18 Mar 2026
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 50,000
- Exercise price
- Footnotes
- F7
MDXH
holding
Derivative
Share Option
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 18 Mar 2026
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 50,000
- Exercise price
- Footnotes
- F8
MDXH
holding
Derivative
Share Option
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 18 Mar 2026
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 50,000
- Exercise price
- Footnotes
- F9
MDXH
holding
Derivative
Share Option
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 18 Mar 2026
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 287,500
- Exercise price
- $2.62
- Footnotes
- F10
MDXH
holding
Derivative
Share Option
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 18 Mar 2026
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 186,875
- Exercise price
- $2.62
- Footnotes
- F11
MDXH
holding
Derivative
Share Option
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 18 Mar 2026
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 500,000
- Exercise price
- $1.47
- Footnotes
- F12
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 12 footnotes
Footnote F1
Represents options to purchase ordinary shares at a price per share of 14.90 Euros granted on February 18, 2019 and issued pursuant to a resolution of an extraordinary general shareholders' meeting on March 16, 2019. The options vest in three equal installments on each of the first three anniversaries of the date of grant.
Footnote F2
Represents options to purchase ordinary shares at a price per share of 8.00 Euros granted on June 24, 2020 and issued pursuant to a resolution of an extraordinary general shareholders' meeting on July 15, 2020. The options vest in three equal installments on each of the first three anniversaries of the date of grant.
Footnote F3
Represents options to purchase ordinary shares at a price per share of 8.00 Euros granted on June 24, 2020 and issued pursuant to a resolution of an extraordinary general shareholders' meeting on July 15, 2020. The options vested upon the achievement of certain Company performance criteria evaluated by the Board of Directors at the end of the relevant performance periods.
Footnote F4
Represents options to purchase ordinary shares at a price per share of 13.75 Euros granted on June 23, 2021 and issued pursuant to a resolution of an extraordinary general shareholders' meeting on July 3, 2021. The options vest in three equal installments on each of the first three anniversaries of the date of grant.
Footnote F5
Represents options to purchase ordinary shares at a price per share of 13.75 Euros granted on June 23, 2021 and issued pursuant to a resolution of an extraordinary general shareholders' meeting on July 3, 2021. The options vested upon the achievement of certain Company performance criteria evaluated by the Board of Directors at the end of the relevant performance periods.
Footnote F6
Represents options to purchase ordinary shares at a price per share of 6.84 Euros granted on May 12, 2022 and issued pursuant to a resolution of an extraordinary general shareholders' meeting on August 3, 2022. The options vest in three equal installments on each of the first three anniversaries of the date of grant.
Footnote F7
Represents options to purchase ordinary shares at a price per share of 6.84 Euros granted on May 12, 2022 and issued pursuant to a resolution of an extraordinary general shareholders' meeting on August 3, 2022. The options vested upon the achievement of certain Company performance criteria evaluated by the Board of Directors at the end of the relevant performance periods.
Footnote F8
Represents options to purchase ordinary shares at a price per share of 2.90 Euros granted on March 21, 2023 and issued pursuant to a resolution of an extraordinary general shareholders' meeting on June 30, 2023. The options vest in three equal installments on each of the first three anniversaries of the date of grant.
Footnote F9
Represents options to purchase ordinary shares at a price per share of 2.90 Euros granted on March 21, 2023 and issued pursuant to a resolution of an extraordinary general shareholders' meeting on June 30, 2023. The options vested upon the achievement of certain Company performance criteria evaluated by the Board of Directors at the end of the relevant performance periods.
Footnote F10
Represents options to purchase ordinary shares at a price per share of $2.62 granted on February 20, 2024 and issued pursuant to a resolution of an extraordinary general shareholders' meeting on June 22, 2024. The options vest in three equal installments on each of the first three anniversaries of the date of grant.
Footnote F11
Represents options to purchase ordinary shares at a price per share of $2.62 granted on February 20, 2024 and issued pursuant to a resolution of an extraordinary general shareholders' meeting on June 22, 2024. The options vested upon the achievement of certain Company performance criteria evaluated by the Board of Directors at the end of the performance periods.
Footnote F12
Represents options to purchase ordinary shares at a price per share of $1.47 granted on March 26, 2025 and issued pursuant to a resolution of an extraordinary general shareholders' meeting on April 11, 2025. The options vest in three equal installments on each of the first three anniversaries of the date of grant.